论文部分内容阅读
目的:对乳腺癌患者行放射性核素全身骨显像,以观察骨转移的发生率及转移部位。方法:100例乳腺癌患者进行前位及后位全身核素骨显像。显像剂为99Tcm-亚甲基二膦酸盐(MDP)。结果:100例乳腺癌患者骨显像示骨转移者33例,阳性率33.3%。乳腺癌骨转移部位以肋骨为最多见(36.4%),其次为脊椎(27.3%),再者为骨盆、肩胛骨、锁骨、胸骨等。结论:乳腺癌患者放射性核素全身骨显像对乳腺癌的分期、治疗方案选择及预后评估均有重要的临床参考价值。
OBJECTIVE: To perform a total body radionuclide bone imaging in patients with breast cancer to observe the incidence of bone metastases and metastatic sites. Methods: 100 cases of breast cancer patients with anterior and posterior systemic radionuclide bone imaging. The imaging agent is 99 Tcm-methylene diphosphonate (MDP). Results: The bone metastases in 100 cases of breast cancer showed bone metastasis in 33 cases, the positive rate was 33.3%. Bone metastasis of breast cancer is the most common bone (36.4%), followed by the spine (27.3%), then the pelvis, scapula, clavicle, sternum and so on. Conclusion: Radionuclide whole body bone imaging in patients with breast cancer has important clinical reference value for staging, treatment options and prognosis evaluation of breast cancer.